Aarti Pharmalabs Limited Total Liabilities

Latest as of June 2025: Rs-19.90 Billion INR ≈ $-215.20 Million USD

Aarti Pharmalabs Limited total liabilities. Based on the latest financial reports, Aarti Pharmalabs Limited (AARTIPHARM) has total liabilities worth Rs-19.90 Billion INR (≈ $-215.20 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Aarti Pharmalabs Limited asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Aarti Pharmalabs Limited (2020–2025)

Total liabilities of Aarti Pharmalabs Limited from 2020 to 2025. This chart illustrates how Aarti Pharmalabs Limited's total liabilities have evolved over time, based on quarterly financial data.

Aarti Pharmalabs Limited Competitors by Total Liabilities

The table below lists competitors of Aarti Pharmalabs Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Oppenheimer Holdings Inc NYSE:OPY	USA	$2.90 Billion
Max Estates Limited NSE:MAXESTATES	India	Rs-31.61 Billion
McEwen Mining Inc. TO:MUX	Canada	CA$319.81 Million
Shanghai Prisemi Electronics Co Ltd SHG:688230	China	CN¥58.91 Million
Shanghai Action Education Technology CO.LTD. SHG:605098	China	CN¥1.21 Billion
Cobram Estate Olives Ltd AU:CBO	Australia	AU$358.24 Million
Chengdu RML Technology Co. Ltd. SHE:301050	China	CN¥735.44 Million
Aksa Akrilik Kimya Sanayi AS IS:AKSA	Turkey	TL32.66 Billion

Liability Composition Analysis (2020–2025)

This chart breaks down Aarti Pharmalabs Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see AARTIPHARM asset base.

Liquidity & Leverage Metrics

Aarti Pharmalabs Limited Total Liabilities Ratios Explained

Aarti Pharmalabs Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	N/A	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.00	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	N/A	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Aarti Pharmalabs Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Aarti Pharmalabs Limited (2020–2025)

The table below shows the annual total liabilities of Aarti Pharmalabs Limited from 2020 to 2025.

Year	Total Liabilities	Change
2025-03-31	Rs9.16 Billion ≈ $99.12 Million	+11.08%
2024-03-31	Rs8.25 Billion ≈ $89.23 Million	+20.35%
2023-03-31	Rs6.86 Billion ≈ $74.14 Million	+4.91%
2022-03-31	Rs6.53 Billion ≈ $70.67 Million	+2807768.13%
2021-03-31	Rs232.71K ≈ $2.52K	+24.61%
2020-03-31	Rs186.75K ≈ $2.02K	--

About Aarti Pharmalabs Limited

NSE:AARTIPHARM India Drug Manufacturers - Specialty & Generic

Market Cap

$908.26 Million

Rs83.98 Billion INR

Market Cap Rank

#9021 Global

#451 in India

Share Price

Rs926.50

Change (1 day)

+0.71%

52-Week Range

Rs591.95 - Rs975.00

All Time High

Rs975.00